LifeMD, Inc. (NASDAQ:LFMDP – Get Free Report) was the target of a significant decline in short interest in September. As of September 30th, there was short interest totaling 1,623 shares, a decline of 37.8% from the September 15th total of 2,609 shares. Based on an average daily volume of 1,248 shares, the days-to-cover ratio is currently 1.3 days.
LifeMD Stock Performance
Shares of LFMDP stock traded up $0.27 during mid-day trading on Friday, hitting $22.27. 832 shares of the stock traded hands, compared to its average volume of 2,177. LifeMD has a 52-week low of $18.50 and a 52-week high of $24.20. The stock’s fifty day moving average is $23.12 and its two-hundred day moving average is $23.41.
LifeMD Announces Dividend
The company also recently disclosed a quarterly dividend, which was paid on Thursday, October 15th. Investors of record on Friday, October 2nd were paid a dividend of $0.5547 per share. This represents a $2.22 annualized dividend and a dividend yield of 10.0%. The ex-dividend date was Friday, October 2nd.
LifeMD Company Profile
LifeMD, Inc is a U.S.-based telehealth company that provides virtual healthcare services through its digital platform. The company connects patients with licensed healthcare professionals for online consultations, medical evaluations, treatment plans, prescription services and, where appropriate, laboratory testing and ongoing care.
LifeMD offers services across several areas of care, including virtual primary care, weight management, men’s health, women’s health, dermatology, sleep care and behavioral health.
See Also
- Five stocks we like better than LifeMD
- Rocket Lab’s Neutron Delay Leaves Wall Street Bullish But Raises the Stakes for 2027
- ManpowerGroup Stock Sinks on Q3 Results, But Fundamentals Stay Solid
- Does the AI Selloff Put Alphabet’s Breakout in Doubt?
- Bank Earnings Are Mixed—These 2 ETFs Offer Very Different Paths to a Recovery
Receive News & Ratings for LifeMD Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifeMD and related companies with MarketBeat.com's FREE daily email newsletter.
